The company has developed a suite of initial products focused on ancestry that will compete with offerings from 23andMe, AncestryDNA, and Family Tree DNA.
The firm said that its metagenomic sequencing-based service provides a broad scope of pathogen testing for people with chronic medical conditions.
The firm is counting on its experience integrating data from the oil and gas industry to change the way pharmaceutical data scientists work.
IDT has licensed the CRISPR/Cpf1 RNA-guided editing system from the Broad Institute and intends to sell it to pharmaceutical and other commercial labs.
One app identifies off-target sites in gene editing experiments while a second app generates a ranked list of CRISPR designs based on gene location and other information.
Version 5.0 of the software features tools for normalizing concepts such as gene mutations and additional query features for mining text documents.
The Workbench Manager helps labs manage their bioinformatics workflows while the Clinical Annotation software offers clinical variant interpretation services.
The company will still provide interpretation-only services, but by adding in-house testing it has dramatically increased its customer base.
Core Informatics has satisfied Good Manufacturing Practice, Good Laboratory Practice, and Good Clinical Practice guidelines for the cloud version of its product.
2bPrecise is developing the needed ontology for its platform to enable clinicians to combine genomic and clinical data in their interactions with pediatric patients.
Startup companies are taking on personalized medicine, CNET reports.
Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.
The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.
In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.